Trial
NCT03971825
A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Celgene
Collaborators
—
Condition
Healthy Volunteers
Intervention
CC-92252
Why stopped
Did not meet progression criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-30